NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug aims to stop diabetic vision loss
Disease control Recruiting nowThis early-stage trial tests an experimental drug called RO7663498, given as an injection into the eye, for people with diabetic retinopathy. The main goal is to check safety and how the drug moves through the body. About 30 participants will receive multiple doses to see if it i…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New eye implant could slow vision loss in diabetes
Disease control Recruiting nowThis Phase 3 trial tests an implant called OTX-TKI that slowly releases the drug axitinib inside the eye. It aims to stop or slow worsening of non-proliferative diabetic retinopathy, a common diabetes complication that can lead to vision loss. About 930 adults with moderate to se…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE3 • Sponsor: Ocular Therapeutix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug ANXV shows promise for common eye diseases in early trial
Disease control Recruiting nowThis study tests a new drug called ANXV in 12 adults with eye diseases from diabetes or blocked retinal veins. The main goal is to check if ANXV is safe and if it can improve vision or reduce the need for other treatments. Participants receive ANXV as a 30-minute infusion for 5 d…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to catch diabetic eye disease before it steals sight
Knowledge-focused Recruiting nowThis study follows 100 people with type 2 diabetes who have moderate to severe diabetic retinopathy, a condition that can lead to vision loss. Researchers will use advanced eye scans and imaging to track changes in the retina over two years. The goal is to find better ways to pre…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC